Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target?

Borzychowski, 2006, Inflammation and pre-eclampsia, Semin Fetal Neonatal Med, 11, 309, 10.1016/j.siny.2006.04.001 Redman, 1991, Current topic: preeclampsia and the placenta, Placenta, 12, 301, 10.1016/0143-4004(91)90339-H Kaufmann, 2003, Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia, Biol Reprod, 69, 1, 10.1095/biolreprod.102.014977 Sarig, 2004, Coagulation, inflammation, and pregnancy complications, Lancet, 363, 96, 10.1016/S0140-6736(03)15309-3 Buhimschi, 1998, The nitric oxide pathway in pre-eclampsia: pathophysiological implications, Hum Reprod Update, 4, 25, 10.1093/humupd/4.1.25 Gomez-Lopez, 2014, Immune cells in term and preterm labor, Cell Mol Immunol, 11, 571, 10.1038/cmi.2014.46 Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126/science.1111726 Burton, 2009, Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy, Placenta, 30, 473, 10.1016/j.placenta.2009.02.009 Soto, 2012, Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion, J Matern Fetal Neonatal Med, 25, 498, 10.3109/14767058.2011.591461 Cotechini, 2014, Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia, J Exp Med, 211, 165, 10.1084/jem.20130295 Cotechini, 2014, Inflammation-induced fetal growth restriction in rats is associated with altered placental morphometrics, Placenta, 35, 575, 10.1016/j.placenta.2014.05.002 Renaud, 2011, Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion, J Immunol, 186, 1799, 10.4049/jimmunol.1002679 Falcon, 2012, Abnormal inflammation leads to maternal coagulopathies associated with placental haemostatic alterations in a rat model of foetal loss, Thromb Haemost, 107, 438, 10.1160/TH11-09-0626 Cotechini, 2012, Nitroglycerin prevents coagulopathies and foetal death associated with abnormal maternal inflammation in rats, Thromb Haemost, 107, 864, 10.1160/TH11-10-0730 Spaans, 2014, Extracellular ATP decreases trophoblast invasion, spiral artery remodeling and immune cells in the mesometrial triangle in pregnant rats, Placenta, 35, 587, 10.1016/j.placenta.2014.05.013 Spaans, 2014, Extracellular adenosine triphosphate affects systemic and kidney immune cell populations in pregnant rats, Am J Reprod Immunol, 72, 305, 10.1111/aji.12267 Redman, 2004, Preeclampsia and the systemic inflammatory response, Semin Nephrol, 24, 565, 10.1016/j.semnephrol.2004.07.005 Sacks, 1998, Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis, Am J Obstet Gynecol, 179, 80, 10.1016/S0002-9378(98)70254-6 Hopkinson, 1992, Classical complement activation induced by pregnancy: implications for management of connective tissue diseases, J Clin Pathol, 45, 66, 10.1136/jcp.45.1.66 Wegmann, 1993, Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?, Immunol Today, 14, 353, 10.1016/0167-5699(93)90235-D Raghupathy, 1997, Th1-type immunity is incompatible with successful pregnancy, Immunol Today, 18, 478, 10.1016/S0167-5699(97)01127-4 Marzi, 1996, Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy, Clin Exp Immunol, 106, 127, 10.1046/j.1365-2249.1996.d01-809.x Gomez-Lopez, 2010, Invasion of the leukocytes into the fetal-maternal interface during pregnancy, J Leukoc Biol, 88, 625, 10.1189/jlb.1209796 Mor, 2011, Inflammation and pregnancy: the role of the immune system at the implantation site, Ann N Y Acad Sci, 1221, 80, 10.1111/j.1749-6632.2010.05938.x Dekel, 2010, Inflammation and implantation, Am J Reprod Immunol, 63, 17, 10.1111/j.1600-0897.2009.00792.x Kelly, 1996, Inflammatory mediators and parturition, Rev Reprod, 1, 89, 10.1530/ror.0.0010089 Thomson, 1999, Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process, Hum Reprod, 14, 229, 10.1093/humrep/14.1.229 Kwak-Kim, 2010, Immunological modes of pregnancy loss, Am J Reprod Immunol, 63, 611, 10.1111/j.1600-0897.2010.00847.x Tosun, 2010, Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia, J Matern Fetal Neonatal Med, 23, 880, 10.3109/14767051003774942 Szarka, 2010, Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array, BMC Immunol, 11, 59, 10.1186/1471-2172-11-59 Lausten-Thomsen, 2014, Inflammatory markers in umbilical cord blood from small-for-gestational-age newborns, Fetal Pediatr Pathol, 33, 114, 10.3109/15513815.2013.879239 Elfayomy, 2013, Serum levels of adrenomedullin and inflammatory cytokines in women with term idiopathic intrauterine growth restriction, J Obstet Gynaecol, 33, 135, 10.3109/01443615.2012.721821 Mallmann, 1991, Determination of tumor necrosis factor alpha (TNF alpha) and interleukin 2 (IL 2) in women with idiopathic recurrent miscarriage, Arch Gynecol Obstet, 249, 73, 10.1007/BF02390365 Vassiliadis, 1998, Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion, Mediat Inflamm, 7, 69, 10.1080/09629359891199 Elovitz, 2003, A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4, Am J Pathol, 163, 2103, 10.1016/S0002-9440(10)63567-5 Sharma, 2007, Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women, Am J Reprod Immunol, 58, 21, 10.1111/j.1600-0897.2007.00486.x Kupferminc, 1996, Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia, Obstet Gynecol, 88, 420, 10.1016/0029-7844(96)00179-2 Kupferminc, 1994, Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia, Am J Obstet Gynecol, 170, 1752, 10.1016/S0002-9378(94)70351-5 Bakheit, 2009, Cytokines profiles in Sudanese women with preeclampsia, Hypertens Pregnancy, 28, 224, 10.1080/10641950802601245 Greer, 1994, Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?, Obstet Gynecol, 84, 937 Gucer, 2001, Maternal serum tumor necrosis factor-alpha in patients with preterm labor, J Reprod Med, 46, 232 Redman, 2010, Immunology of pre-eclampsia, Am J Reprod Immunol, 63, 534, 10.1111/j.1600-0897.2010.00831.x Wilson, 2004, Abnormal cytokine levels in non-pregnant women with a history of recurrent miscarriage, Eur J Obstet Gynecol Reprod Biol, 115, 51, 10.1016/j.ejogrb.2003.11.029 Bodnar, 2005, The risk of preeclampsia rises with increasing prepregnancy body mass index, Ann Epidemiol, 15, 475, 10.1016/j.annepidem.2004.12.008 Redman, 1999, Preeclampsia: an excessive maternal inflammatory response to pregnancy, Am J Obstet Gynecol, 180, 499, 10.1016/S0002-9378(99)70239-5 Faas, 1994, A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats, Am J Obstet Gynecol, 171, 158, 10.1016/0002-9378(94)90463-4 Girardi, 2003, Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome, J Clin Invest, 112, 1644, 10.1172/JCI200318817 Salmon, 2003, Activation of complement mediates antiphospholipid antibody-induced pregnancy loss, Lupus, 12, 535, 10.1191/0961203303lu397oa Girardi, 2004, Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation, Nat Med, 10, 1222, 10.1038/nm1121 Berman, 2005, TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss, J Immunol, 174, 485, 10.4049/jimmunol.174.1.485 Parameswaran, 2010, Tumor necrosis factor-alpha signaling in macrophages, Crit Rev Eukaryot Gene Expr, 20, 87, 10.1615/CritRevEukarGeneExpr.v20.i2.10 Djeu, 1990, Release of tumor necrosis factor by human polymorphonuclear leukocytes, Blood, 76, 1405, 10.1182/blood.V76.7.1405.1405 Boussiotis, 1994, Tumor-necrosis-factor-alpha is an autocrine growth-factor for normal human B-cells, Proc Natl Acad Sci USA, 91, 7007, 10.1073/pnas.91.15.7007 Takashima, 1990, Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis, Infect Immun, 58, 3286, 10.1128/IAI.58.10.3286-3292.1990 Albaugh, 2001, Nicotine induces endothelial TNF-alpha expression, which mediates growth retardation in vitro, J Surg Res, 99, 381, 10.1006/jsre.2001.6215 Li, 1992, Trophoblast-derived tumor-necrosis-factor-alpha induces release of human Chorionic-Gonadotropin using Interleukin-6 (Il-6) and Il-6-receptor-dependent system in the Normal human trophoblasts, J Clin Endocrinol Metab, 74, 184 Benyo, 1997, Hypoxia stimulates cytokine production by villous explants from the human placenta, J Clin Endocrinol Metab, 82, 1582 Heyborne, 1992, Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth, Am J Obstet Gynecol, 167, 920, 10.1016/S0002-9378(12)80012-3 Wang, 1996, TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas, J Reprod Immunol, 32, 157, 10.1016/S0165-0378(96)00998-9 Gorivodsky, 1998, TNF-alpha messenger RNA and protein expression in the uteroplacental unit of mice with pregnancy loss, J Immunol, 160, 4280, 10.4049/jimmunol.160.9.4280 Marusic, 2013, Expression of inflammatory cytokines in placentas from pregnancies complicated with preeclampsia and HELLP syndrome, J Matern Fetal Neonatal Med, 26, 680, 10.3109/14767058.2012.746301 Benyo, 2001, Expression of inflammatory cytokines in placentas from women with preeclampsia, J Clin Endocrinol Metab, 86, 2505 Burton, 2014, Optimising sample collection for placental research, Placenta, 35, 9, 10.1016/j.placenta.2013.11.005 Renaud, 2005, Activated macrophages inhibit human cytotrophoblast invasiveness in vitro, Biol Reprod, 73, 237, 10.1095/biolreprod.104.038000 Bauer, 2004, Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures, J Clin Endocrinol Metab, 89, 812, 10.1210/jc.2003-031351 Alexander, 2002, Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression, Am J Hypertens, 15, 170, 10.1016/S0895-7061(01)02255-5 LaMarca, 2005, Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats, Hypertension, 46, 82, 10.1161/01.HYP.0000169152.59854.36 LaMarca, 2005, Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha, Hypertension, 46, 1022, 10.1161/01.HYP.0000175476.26719.36 van der Poll, 1990, Activation of coagulation after administration of tumor necrosis factor to normal subjects, N Engl J Med, 322, 1622, 10.1056/NEJM199006073222302 Schafer, 1985, The hypercoagulable states, Ann Intern Med, 102, 814, 10.7326/0003-4819-102-6-814 Holmes, 2005, Haemostasis in normal pregnancy: a balancing act?, Biochem Soc Trans, 33, 428, 10.1042/BST0330428 Stirling, 1984, Haemostasis in normal pregnancy, Thromb Haemost, 52, 176, 10.1055/s-0038-1661167 Bremme, 2003, Haemostatic changes in pregnancy, Best Pract Res Clin Haematol, 16, 153, 10.1016/S1521-6926(03)00021-5 Thornton, 2010, Coagulation in pregnancy, Best Pract Res Clin Obstet Gynaecol, 24, 339, 10.1016/j.bpobgyn.2009.11.010 Kitzmiller, 1973, Immunofluorescent study of placental bed vessels in pre-eclampsia of pregnancy, Am J Obstet Gynecol, 115, 248, 10.1016/0002-9378(73)90293-7 Salafia, 1992, Placental pathology of idiopathic intrauterine growth retardation at term, Am J Perinatol, 9, 179, 10.1055/s-2007-999316 Naeye, 1977, Placental infarction leading to fetal or neonatal death. A prospective study, Obstet Gynecol, 50, 583 Mello, 2005, Thrombophilia is significantly associated with severe preeclampsia - results of a large-scale, case-controlled study, Hypertension, 46, 1270, 10.1161/01.HYP.0000188979.74172.4d Howley, 2005, A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction, Am J Obstet Gynecol, 192, 694, 10.1016/j.ajog.2004.09.011 Kovalevsky, 2004, Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss - a meta-analysis, Arch Intern Med, 164, 558, 10.1001/archinte.164.5.558 Sarig, 2002, Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage, Fertil Steril, 77, 342, 10.1016/S0015-0282(01)02971-5 Dizon-Townson, 2005, The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus, Obstet Gynecol, 106, 517, 10.1097/01.AOG.0000173986.32528.ca Rodger, 2014, Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study, J Thromb Haemost, 12, 469, 10.1111/jth.12509 Rodger, 2011, Anticoagulant prophylaxis for placenta mediated pregnancy complications, Thromb Res, 127, S76, 10.1016/S0049-3848(11)70021-4 Redline, 2006, Thrombophilia and placental pathology, Clin Obstet Gynecol, 49, 885, 10.1097/01.grf.0000211957.68745.6b Isermann, 2003, The thrombomodulin-protein C system is essential for the maintenance of pregnancy, Nat Med, 9, 331, 10.1038/nm825 Levi, 2004, Bidirectional relation between inflammation and coagulation, Circulation, 109, 2698, 10.1161/01.CIR.0000131660.51520.9A Wenzel, 1995, Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells, Circ Res, 77, 503, 10.1161/01.RES.77.3.503 Murakami, 1996, Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats, Blood, 87, 642, 10.1182/blood.V87.2.642.bloodjournal872642 Okajima, 2001, Regulation of inflammatory responses by natural anticoagulants, Immunol Rev, 184, 258, 10.1034/j.1600-065x.2001.1840123.x Cumming, 1995, Development of resistance to activated protein C during pregnancy, Br J Haematol, 90, 725, 10.1111/j.1365-2141.1995.tb05610.x Kwak-Kim, 2009, Recurrent pregnancy loss: a disease of inflammation and coagulation, J Obstet Gynaecol Res, 35, 609, 10.1111/j.1447-0756.2009.01079.x Li, 2009, Innate immunity, coagulation and placenta-related adverse pregnancy outcomes, Thromb Res, 124, 656, 10.1016/j.thromres.2009.07.012 Nawroth, 1986, Modulation of endothelial cell hemostatic properties by tumor necrosis factor, J Exp Med, 163, 740, 10.1084/jem.163.3.740 Levi, 1994, Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees, J Clin Invest, 93, 114, 10.1172/JCI116934 Erez, 2008, Tissue factor and its natural inhibitor in pre-eclampsia and SGA, J Matern Fetal Neonatal Med, 21, 855, 10.1080/14767050802361872 Teng, 2010, The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients, Thromb Res, 126, E41, 10.1016/j.thromres.2010.02.012 Godoi, 2012, Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor, J Thromb Thrombolysis, 34, 1, 10.1007/s11239-012-0708-8 Gardiner, 2011, Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity, PLoS One, 6, e26313, 10.1371/journal.pone.0026313 Fleck, 1990, Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody, Thromb Res, 59, 421, 10.1016/0049-3848(90)90148-6 Girardi, 2011, Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation, Thromb Res, 127, S43, 10.1016/S0049-3848(11)70012-3 Germain, 2007, Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles, J Immunol, 178, 5949, 10.4049/jimmunol.178.9.5949 Joerger-Messerli, 2014, Stimulation of monocytes by placental microparticles involves toll-like receptors and nuclear factor kappa-light-chain-enhancer of activated B cells, Front Immunol, 5, 173, 10.3389/fimmu.2014.00173 Dekker, 1991, Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia, Eur J Obstet Gynecol Reprod Biol, 40, 215, 10.1016/0028-2243(91)90120-A Davis, 2002, Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats, Am J Physiol Regul Integr Comp Physiol, 282, R390, 10.1152/ajpregu.00270.2001 Orshal, 2004, Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats, Hypertension, 43, 434, 10.1161/01.HYP.0000113044.46326.98 Leonard, 2013, Gestational modification of murine spiral arteries does not reduce their drug-induced vasoconstrictive responses in situ, Placenta, 34, A58, 10.1016/j.placenta.2013.06.175 Jauniaux, 2006, Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution, Hum Reprod Update, 12, 747, 10.1093/humupd/dml016 Schieber, 2014, ROS function in redox signaling and oxidative stress, Curr Biol, 24, R453, 10.1016/j.cub.2014.03.034 Bae, 2011, Regulation of reactive oxygen species generation in cell signaling, Mol Cell, 32, 491, 10.1007/s10059-011-0276-3 Bonello, 2007, Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site, Arterioscler Thromb Vasc Biol, 27, 755, 10.1161/01.ATV.0000258979.92828.bc Rius, 2008, NF-kappa B links innate immunity to the hypoxic response through transcriptional regulation of HIF-1 alpha, Nature, 453, 807, 10.1038/nature06905 Bartels, 2013, Hypoxia and inflammation are two sides of the same coin, Proc Natl Acad Sci USA, 110, 18351, 10.1073/pnas.1318345110 Cummins, 2006, Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity, Proc Natl Acad Sci USA, 103, 18154, 10.1073/pnas.0602235103 Lunell, 1982, Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera, Clin Exp Hypertens B, 1, 105, 10.3109/10641958209037184 Ananth, 2014, Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption, Semin Perinatol, 38, 131, 10.1053/j.semperi.2014.03.001 Rajakumar, 2004, Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae, Placenta, 25, 763, 10.1016/j.placenta.2004.02.011 Caniggia, 2002, Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies–a review, Placenta, 23, S47, 10.1053/plac.2002.0815 Roggensack, 1999, Evidence for peroxynitrite formation in the vasculature of women with preeclampsia, Hypertension, 33, 83, 10.1161/01.HYP.33.1.83 Le, 2001, Nitric oxide production in the hypoxic lung, Am J Physiol Lung Cell Mol Physiol, 280, L575, 10.1152/ajplung.2001.280.4.L575 McCormick, 2000, Oxygen tension limits nitric oxide synthesis by activated macrophages, Biochem J, 350, 709, 10.1042/bj3500709 Whorton, 1997, Regulation of nitric oxide synthesis by oxygen in vascular endothelial cells, Am J Physiol, 272, L1161 Choi, 2002, Nitric oxide production increases during normal pregnancy and decreases in preeclampsia, Ann Clin Lab Sci, 32, 257 Krause, 2011, Role of nitric oxide in placental vascular development and function, Placenta, 32, 797, 10.1016/j.placenta.2011.06.025 Seligman, 1994, The role of nitric oxide in the pathogenesis of preeclampsia, Am J Obstet Gynecol, 171, 944, 10.1016/S0002-9378(94)70064-8 Neerhof, 2011, Pathophysiology of chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat, Hypertens Pregnancy, 30, 28, 10.3109/10641950903322915 Wight, 1998, Chronic blockade of nitric oxide-synthase and endothelin receptors during pregnancy in the rat: effect on pregnancy outcome, J Soc Gynecol Invest, 5, 132, 10.1016/S1071-5576(98)00004-5 Wareing, 2005, Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction, J Clin Endocrinol Metab, 90, 2550, 10.1210/jc.2004-1831 Dastjerdi, 2012, Sildenafil citrate and uteroplacental perfusion in fetal growth restriction, J Res Med Sci, 17, 632 Ramesar, 2010, Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats, Eur J Obstet Gynecol Reprod Biol, 149, 22, 10.1016/j.ejogrb.2009.11.005 Herraiz, 2012, Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats, BJOG, 119, 1394, 10.1111/j.1471-0528.2012.03430.x Moro, 1996, cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase, Proc Natl Acad Sci USA, 93, 1480, 10.1073/pnas.93.4.1480 Chirkov, 1992, Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects, Am J Cardiol, 70, 802, 10.1016/0002-9149(92)90563-E Artz, 2001, In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics, Biochemistry, 40, 9256, 10.1021/bi002885x Mulsch, 1995, Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo, Br J Pharmacol, 116, 2743, 10.1111/j.1476-5381.1995.tb17236.x Nunez, 2005, Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO, Circ Res, 97, 1063, 10.1161/01.RES.0000190588.84680.34 Torfgard, 1997, Mechanisms of action of nitrates, Cardiovasc Drugs Ther, 8, 701, 10.1007/BF00877117 Kleschyov, 2003, Does nitric oxide mediate the vasodilator activity of nitroglycerin?, Circ Res, 93, E104, 10.1161/01.RES.0000100067.62876.50 Smith, 1998, Use of nitroglycerin for uterine relaxation, Obstet Gynecol Surv, 53, 559, 10.1097/00006254-199809000-00023 Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189 Venkatesha, 2006, Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, 12, 642, 10.1038/nm1429 Gilbert, 2007, Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression, Hypertension, 50, 1142, 10.1161/HYPERTENSIONAHA.107.096594 Murphy, 2013, Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-alpha, Am J Physiol Regul Integr Comp Physiol, 304, R130, 10.1152/ajpregu.00069.2012 Barsoum, 2011, Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues, Am J Pathol, 178, 2888, 10.1016/j.ajpath.2011.02.013 Lamarca, 2011, Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation, Int J Interferon, Cytokine Mediat Res: IJIM, 2011, 65, 10.2147/IJICMR.S22329 Gadonski, 2006, Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6, Hypertension, 48, 711, 10.1161/01.HYP.0000238442.33463.94 Wallace, 2011, CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy, Hypertension, 57, 949, 10.1161/HYPERTENSIONAHA.110.168344 Faas, 1995, Glomerular inflammation in pregnant rats after infusion of low dose endotoxin. An immunohistological study in experimental pre-eclampsia, Am J Pathol, 147, 1510 Lin, 2012, Treatment of Lipoxin A(4) and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms, Reprod Toxicol, 34, 677, 10.1016/j.reprotox.2012.09.009 Rivera, 1998, Interleukin-10 attenuates experimental fetal growth restriction and demise, FASEB J, 12, 189, 10.1096/fasebj.12.2.189 Branch, 1990, Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss, Am J Obstet Gynecol, 163, 210, 10.1016/S0002-9378(11)90700-5 Faas, 2010, Extracellular ATP induces albuminuria in pregnant rats, Nephrol Dial Transpl, 25, 2468, 10.1093/ndt/gfq095 Girardi, 2006, Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction, J Exp Med, 203, 2165, 10.1084/jem.20061022 Ahmed, 2010, A new mouse model to explore therapies for preeclampsia, PLoS One, 5, e13663, 10.1371/journal.pone.0013663 Dixon, 2006, Failure of decidual arteriolar remodeling in the CBA/J x DBA/2 murine model of recurrent pregnancy loss is linked to increased expression of tissue inhibitor of metalloproteinase 2 (TIMP-2), Am J Obstet Gynecol, 194, 113, 10.1016/j.ajog.2005.06.063